Addex Therapeutics Ltd ADXN
3.40 USD +0.34 (+11.11%)
Regular-session close
3.39 -0.01 -0.19%
Pre-market · Nov 20, 5:02 AM ET
3.19 Day range 3.65
2.56 52-week range 10.43
- YTD
- -55.96%
- 1 year
- -62.05%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 172.86K | 410.04K | 1.62M | 1.44M | 3.15M | |
| 172.86K | 410.04K | 1.62M | 1.44M | 3.15M | |
| -2.81M | -2.76M | -2.24M | -10.54M | -15.51M | |
| -6.73M | 7.06M | -10.56M | -20.80M | -15.35M | |
| -0.06 | 0.07 | -0.14 | -0.46 | -0.45 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.64M | 3.34M | 3.87M | 6.96M | 20.48M | |
| 6.36M | 10.68M | 4.64M | 8.28M | 22.54M | |
| 1.60M | 1.00M | 3.50M | 3.37M | 5.61M | |
| 34.69K | 41.99K | 344.34K | 373.13K | 482.01K | |
| 4.77M | 9.68M | 1.15M | 4.91M | 16.93M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -2.17M | -5.37M | -7.99M | -16.44M | -14.71M | |
| -680.69K | 4.65M | -6.84K | 2.97K | -30.31K | |
| 1.18M | 104.92K | 5.26M | 3.10M | 16.40M | |
| -1.67M | -623.42K | -2.73M | -13.33M | 1.67M |
